相关实验视频
Updated: Jun 23, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
通过雌激素介导的DNMT1和DNMT3A由EZH2的招募使得miR-570-3p沉默,该miR-570-3p通过DPP4促进皮质甲状腺恶性瘤
Xiarong Hu1, Qingyao Ye1, HuanQuan Lu1
1Department of General Surgery, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, 523059, Guangdong, China.
Clinical epigenetics
|June 18, 2024
概括
雌激素通过通过EZH2/DNMTs通路增加miR-570-3p甲基化来促进乳头甲状腺癌 (PTC) 的生长. 这种表观遗传调节降低了miR-570-3p的调节,增强了瘤的进展.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 乳头甲状腺癌 (PTC) 是一种普遍存在的内分泌恶性瘤.
- 雌激素在调节微RNAs (miRNAs) 的作用在各种癌症中得到了认可.
- 在PTC中,miR-570-3p的特定功能及其与雌激素的联系仍未得到充分研究.
研究的目的:
- 研究miR-570-3p在PTC中的调节作用.
- 在PTC中确定雌激素 (特别是雌二醇E2) 和miR-570-3p之间的直接关联.
- 阐明雌激素对miR-570-3p表达和PTC进展的影响的分子机制.
主要方法:
- 生物信息预测和qRT-PCR/西斑验证miR-570-3p和DPP4表达.
- 为了评估miR-570-3p/DPP4轴功能的体外和体内损益实验.
- 对miR-570-3p促进物甲基化 (MSP) 和EZH2/DNMTs/E2相互作用 (露西法酶,ChIP,co-IP测试) 的分析.
主要成果:
- 在PTC组织/细胞中,miR-570-3p的下调和高甲基化.
- DPP4被确定为miR-570-3p的直接标;miR-570-3p抑制了PTC细胞的增殖,迁移,入侵,并促进了细胞亡,DPP4的效应被逆转.
- 雌激素 (E2) 通过EZH2 / DNMTs增加了miR-570-3p促进剂甲基化,减少了miR-570-3p表达并促进了PTC生长.
结论:
- 雌激素通过表观遗传沉默miR-570-3p促进PTC进展.
- 通过EZH2/DNMTs途径调解雌激素诱导的miR-570-3p抑制.
- miR-570-3p/DPP4轴是由雌激素调节的PTC发育中的关键参与者.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Epigenetic Regulation
31.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K

